Visage Ease vs Neurosurgery Nomogram

Using Visage Ease you can view radiologic images that are stored on a Visage 7 server on your iPad, iPhone, and iPod Touch. Please note that this app requires access to a Visage 7 server, e.g. in your clinic, practice, or via your radiology provider. Without access to a server, you will not be able to view any images. Visage Ease provides you with immediate server-based access to DICOM images without cumbersome image transfer. Use the app for patient education and for illustrating findings in the diagnostic report. Radiology providers use the Visage 7 server in conjunction with Visage Ease to provide their referring physicians with efficient access to key images as well as original images. Compared to printed film or patient CDs, the Visage 7 solution provides a much richer and much more efficient means of communication. Visage 7 is the world’s first diagnostic imaging solution based entirely on efficient thin client streaming technology. Visage scales easily from a single radiology practice to large distributed healthcare enterprises. Visage allows efficient viewing, processing, and archiving of very large amounts of images, including thin slice volumetric data from CT, MR, PET-CT, and other 3D modalities. The Visage Ease App is not a medical device and must not be used for diagnosis. A "Getting Started" document is available here: http://www.visageimaging.com/e-labeling

Unlock advanced neuro-oncology analytics with this clinical-grade prognostic tool. Powered by extensive data from the Surveillance, Epidemiology, and End Results (SEER) Program (2000–2023), the app delivers robust, tumor-specific nomogram models to predict individualized survival outcomes at user-defined timepoints from 0 to 120 months. Designed for seamless clinical and research navigation, the application translates complex epidemiological data into interactive, visual insights across a wide spectrum of central nervous system and brain tumors. Tumor Types: Astrocytoma, Ependymoma, Esthesioneuroblastoma, Glioma, Glioblastoma, Medulloblastoma, Meningioma, Oligodendroglioma, Pilocytic Astrocytoma, Pleomorphic Xanthoastrocytoma, Posterior Fossa Glioblastoma and Schwannoma. Rigorous Statistical Testing Internal Validation: 500-sample bootstrapping built with optimism-corrected calibration. External Validation: Temporal validation utilizing an 80% training and 20% testing cohort split. Interactive Workspace Tabs Kaplan-Meier Curves: Survival analysis. Forest Plot: Hazard ratio and variable visualization. Treatment Comparison: Evaluate multi-modal therapeutic strategies. Calibration, Discrimination & Validation Metrics: Verify model accuracy in real-time.